scroll to top

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "prostate cancer"

1 - 10 of 155,835 results for
 "prostate cancer"
Results per page:

Increasing aggressive prostate cancer.

Publication Type: Academic Journal

Source(s): The Canadian journal of urology [Can J Urol] 2022 Dec; Vol. 29 (6), pp. 11384-11390.

Abstract: Introduction: To compare prostate biopsy (Pbx) characteristics, before and after the 2012 United States Preventive Services Task Force (USPSTF) prostate cancer screening guidelines in our practice.Materials and Methods: We completed a retrospective com...

Design and Implementation of Taizhou Integrated Prostate Screening.

Publication Type: Academic Journal

Source(s): American journal of men's health [Am J Mens Health] 2022 Nov-Dec; Vol. 16 (6), pp. 15579883221138192.

Abstract: A community-based prostate cancer screening program was conducted to assess the morbidity and associated factors for prostate cancer among the subpopulation of men aged ≥50 years in Taizhou, China. Taizhou Integrated Prostate Screening (TIPS) is a larg...

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial.

Publication Type: Academic Journal

Source(s): European urology [Eur Urol] 2022 Sep; Vol. 82 (3), pp. 311-317. Date of Electronic Publication: 2022 Feb 01.

Abstract: Background: Studies have suggested associations between greater age, increased risk of prostate cancer (PC), and higher Gleason score.Objective: The present study aimed at investigating these associations within the Göteborg-1 randomized, population-ba...

Prostate cancer screening - is it time to change approach?

Publication Type: Academic Journal

Source(s): Central European journal of public health [Cent Eur J Public Health] 2022 Jun; Vol. 30 (Supplement), pp. S11-S15.

Abstract: Objective: Prostate adenocarcinoma (CaP) is one of the most common malignancies in men in Slovakia and in the world. The disease accounts for more than 22% of all tumors in the male population. Screening studies show an increase in the diagnosis of CaP...

Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.

Publication Type: Academic Journal

Source(s): Frontiers in immunology [Front Immunol] 2022 Aug 18; Vol. 13, pp. 901176. Date of Electronic Publication: 2022 Aug 18 (Print Publication: 2022).


Abstract: Objective: To identify less invasive and easily applicable serum cytokine-derived biomarkers which contribute to the diagnostic utility and risk assessment ability of the prostate health index (PHI) based multivariable model in grey zone aggressive pro...

The Effectiveness of Prostate Imaging and Reporting and Data System Version 2 in the Diagnosis of Prostate Cancer with Screening Parameters Correlation.

Publication Type: Academic Journal

Source(s): Archivos espanoles de urologia [Arch Esp Urol] 2022 Jun; Vol. 75 (5), pp. 416-422.

Abstract: Purpose: Prostate cancer is the most commonly diagnosed cancer and the second most common reason for cancer-related mortality in men. The purpose of cancer screening is to detect the disease at an early stage to help effective treatment. This study aim...

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer.

Publication Type: Academic Journal

Source(s): International journal of cancer [Int J Cancer] 2023 Feb 15; Vol. 152 (4), pp. 672-678. Date of Electronic Publication: 2022 Sep 15.

Abstract: Prostate-specific antigen (PSA)-based screening for prostate cancer (PCa) can reduce PCa mortality, but also involves overdetection of low-risk disease with potential adverse effects. We evaluated PCa incidence among men with PSA below 3 ng/mL and no P...

Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing.

Publication Type: Report

Source(s): Journal of medical screening [J Med Screen] 2022 Dec; Vol. 29 (4), pp. 268-271. Date of Electronic Publication: 2022 Sep 04.

Abstract: Objective: To summarise and compare the key recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer, and so highlight where more evidence is required to facilitate consistent recommendations.Methods: The Medline database ...

Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.

Publication Type: Academic Journal

Source(s): Cancer [Cancer] 2023 Jan 01; Vol. 129 (1), pp. 82-88. Date of Electronic Publication: 2022 Nov 07.

Abstract: Background: The 2018 US Preventive Services Task Force guidelines recommend individualizing prostate cancer screening in 55- to 69-year-old men. Given the higher incidence of prostate cancer in African American (AA) compared to non-Hispanic White (NHW)...

Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer.

Publication Type: Academic Journal

Source(s): European urology oncology [Eur Urol Oncol] 2022 Aug; Vol. 5 (4), pp. 430-439. Date of Electronic Publication: 2021 Mar 31.


Abstract: Background: Despite biomarker development advances, early detection of aggressive prostate cancer (PCa) remains challenging. We previously developed a clinical-grade urine test (Michigan Prostate Score [MiPS]) for individualized aggressive PCa risk pre...